Single Nucleotide Polymorphism Profiling Assay to Confirm the Identity of Human Tissues
2007; Elsevier BV; Volume: 9; Issue: 2 Linguagem: Inglês
10.2353/jmoldx.2007.060059
ISSN1943-7811
AutoresRonald Huijsmans, Jan Damen, Hans van der Linden, Mirjam H. A. Hermans,
Tópico(s)RNA modifications and cancer
ResumoTo identify issues of sample mix-ups, various molecular techniques are currently used. These techniques, however, are time consuming and require experience and/or DNA sequencing equipment or have a relatively high risk of errors because of contamination. Therefore, a quick and straightforward single nucleotide polymorphism (SNP) profiling assay was developed to link human tissues to a source. SNPs are common sequence variations in the human genome, and each individual has a unique combination of these nucleotide variations. Using potentially mislabeled paraffin-embedded tissues, DNA was extracted and SNP profiles were determined by real-time polymerase chain reaction analysis of the purified DNA using a selection of 10 commercially available SNP amplification assays. These profiles were compared with profiles of the supposed owners. All issues (34 in total) of potential sample mix-ups during the last 3 years were adequately solved, with six cases described here. The SNP profiling assay provides a quick (within 24 hours), easy, and reliable way to link human samples to a source, without polymerase chain reaction postprocessing. The chance for two randomly chosen individuals to have an identical profile is 1 in 18,000. Solving potential sample mix-ups will secure downstream evaluations and critical decisions concerning the patients involved. To identify issues of sample mix-ups, various molecular techniques are currently used. These techniques, however, are time consuming and require experience and/or DNA sequencing equipment or have a relatively high risk of errors because of contamination. Therefore, a quick and straightforward single nucleotide polymorphism (SNP) profiling assay was developed to link human tissues to a source. SNPs are common sequence variations in the human genome, and each individual has a unique combination of these nucleotide variations. Using potentially mislabeled paraffin-embedded tissues, DNA was extracted and SNP profiles were determined by real-time polymerase chain reaction analysis of the purified DNA using a selection of 10 commercially available SNP amplification assays. These profiles were compared with profiles of the supposed owners. All issues (34 in total) of potential sample mix-ups during the last 3 years were adequately solved, with six cases described here. The SNP profiling assay provides a quick (within 24 hours), easy, and reliable way to link human samples to a source, without polymerase chain reaction postprocessing. The chance for two randomly chosen individuals to have an identical profile is 1 in 18,000. Solving potential sample mix-ups will secure downstream evaluations and critical decisions concerning the patients involved. The clinically significant diagnostic error rate in surgical pathology reported in the literature varies from 0.08 to 1.2%.1Lind AC Bewtra C Healy JC Sims KL Prospective peer review in surgical pathology.Am J Clin Pathol. 1995; 104: 560-566PubMed Google Scholar2Renshaw AA Young ML Jiroutek MR How many cases need to be reviewed to compare performance in surgical pathology?.Am J Clin Pathol. 2003; 119: 388-391Crossref PubMed Scopus (24) Google Scholar3Renshaw AA Cartagena N Granter SR Gould EW Agreement and error rates using blinded review to evaluate surgical pathology of biopsy material.Am J Clin Pathol. 2003; 119: 797-800Crossref PubMed Scopus (55) Google Scholar4Ramsay AD Gallagher PJ Local audit of surgical pathology. 18 month's experience of peer review-based quality assessment in an English teaching hospital.Am J Surg Pathol. 1992; 16: 476-482Crossref PubMed Scopus (64) Google Scholar5Safrin RE Bark CJ Surgical pathology sign-out. Routine review of every case by a second pathologist.Am J Surg Pathol. 1993; 17: 1190-1192Crossref PubMed Scopus (98) Google Scholar6Wakely SL Baxendine-Jones JA Gallagher PJ Mullee M Pickering R Aberrant diagnoses by individual surgical pathologists.Am J Surg Pathol. 1998; 22: 77-82Crossref PubMed Scopus (40) Google Scholar One of the factors contributing to these errors is misidentification of paraffin-embedded tissue, the most commonly used material for diagnostic purposes. Although specimen identification is a carefully controlled factor in clinical laboratories, mislabeling still occurs. Unfortunately, sample mix-ups can have extremely serious consequences for the patients involved. Various methods to detect specimen mix-ups have been described. Most methods rely on characterization of DNA repeats,7Koyama H Iwasa M Tsuchimochi T Maeno Y Isobe I Matsumoto T Nagao M Utility of Y-STR haplotype and mtDNA sequence in personal identification of human remains.Am J Forensic Med Pathol. 2002; 23: 181-185Crossref PubMed Scopus (7) Google Scholar8Moretti TR Baumstark AL Defenbaugh DA Keys KM Smerick JB Budowle B Validation of short tandem repeats (STRs) for forensic usage: performance testing of fluorescent multiplex STR systems and analysis of authentic and simulated forensic samples.J Forensic Sci. 2001; 46: 647-660PubMed Google Scholar9Romero RL Juston AC Ballantyne J Henry BE The applicability of formalin-fixed and formalin fixed paraffin embedded tissues in forensic DNA analysis.J Forensic Sci. 1997; 42: 708-714PubMed Google Scholar human leukocyte antigen system (HLA),10Bateman AC Sage DA Al-Talib RK Theaker JM Jones DB Howell WM Investigation of specimen mislabelling in paraffin-embedded tissue using a rapid, allele-specific, PCR-based HLA class II typing method.Histopathology. 1996; 28: 169-174Crossref PubMed Scopus (15) Google Scholar11Bateman AC Hemmatpour SK Theaker JM Howell WM Genetic analysis of hydatidiform moles in paraffin wax embedded tissue using rapid, sequence specific PCR-based HLA class II typing.J Clin Pathol. 1997; 50: 288-293Crossref PubMed Scopus (8) Google Scholar12Giroti R Kashyap VK Detection of the source of mislabeled biopsy tissue paraffin block and histopathological section on glass slide.Diagn Mol Pathol. 1998; 7: 331-334Crossref PubMed Scopus (9) Google Scholar13Shibata D Namiki T Higuchi R Identification of a mislabeled fixed specimen by DNA analysis.Am J Surg Pathol. 1990; 14: 1076-1078Crossref PubMed Scopus (23) Google Scholar14Shibata D Kurosu M Noguchi TT Fixed human tissues: a resource for the identification of individuals.J Forensic Sci. 1991; 36: 1204-1212PubMed Google Scholar15Tsongalis GJ Berman MM Application of forensic identity testing in a clinical setting. Specimen identification.Diagn Mol Pathol. 1997; 6: 111-114Crossref PubMed Scopus (21) Google Scholar or other polymorphic genetic loci.14Shibata D Kurosu M Noguchi TT Fixed human tissues: a resource for the identification of individuals.J Forensic Sci. 1991; 36: 1204-1212PubMed Google Scholar In addition, commercial identification kits are available.16Baird ML Use of the AmpliType PM + HLA DQA1 PCR amplification and typing kits for identity testing.Methods Mol Biol. 1998; 98: 261-277PubMed Google Scholar17Tsongalis GJ Wu AH Silver H Ricci Jr, A Applications of forensic identity testing in the clinical laboratory.Am J Clin Pathol. 1999; 112: S93-S103PubMed Google Scholar18Walsh PS Fildes N Louie AS Higuchi R Report of the blind trial of the Cetus Amplitype HLA DQ alpha forensic deoxyribonucleic acid (DNA) amplification and typing kit.J Forensic Sci. 1991; 36: 1551-1556Crossref PubMed Google Scholar Because these methods are time consuming and/or require DNA sequencing equipment, which is not available in many laboratories, we developed an easy, quick, and reliable method to link human tissues to a source. The method relies on the analysis of carefully selected SNPs by means of real-time polymerase chain reaction (PCR). Single nucleotide polymorphisms (SNPs) are the most frequent sequence variations in the human genome, occurring approximately once every 100 to 300 bp.19Casey D Scientists Hunt SNPs to Uncover Variation, Disease. Human Genome Program, U.S. Department of Energy. Human Genome News, Washington, DC1999: 10Google Scholar Apart from identical twins, each individual has a unique combination of nucleotides at these positions. Thus, a SNP profile provides a kind of fingerprint. SNP amplification assays have been commercially developed using DNA probes with conjugated minor groove binding (MGB) groups.20Afonina I Kutyavin I Lukhtanov E Meyer RB Gamper H Sequence-specific arrest of primer extension on single-stranded DNA by an oligonucleotide-minor groove binder conjugate.Proc Natl Acad Sci USA. 1996; 93: 3199-3204Crossref PubMed Scopus (33) Google Scholar These probes form extremely stable duplexes with single-stranded DNA targets, thus allowing short probes to be used for hybridization-based assays. In this article, we describe a SNP profiling test for human tissues using 10 SNP assays that were selected on the basis of allele frequency and chromosomal location. By comparison, of the SNP profiles obtained from relevant samples, the test can reliably confirm the identity of human materials. The test can be used to detect sample mix-ups and to evaluate quality surveillance of sample handling and storage. Tissues were fixed in 0.01 mol/L buffered (0.005 mol/L disodium hydrogen phosphate anhydrous and 0.005 mol/L sodium dihydrogen phosphate dihydrate, pH 7.0) 10% formalin, and processed for paraffin embedding using a Tissue-Tek VIP 5 (Sakura, Torrance, CA). The program consisted of 14 steps of 1 hour under continuous agitation, pressure, vacuum, and heating. At 40°C, two 10% formalin steps were followed by one 70% (v/v) ethanol step, two 96% ethanol steps, three 100% ethanol steps, and two 100% xylene steps. Paraffin embedding was done at 60°C in four 100% paraffin steps. DNA was extracted from 200 μl of blood with the QIAamp DNA blood mini kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions and eluted in 150 μl of buffer AE (Qiagen). Paraffin-embedded tissues were trimmed of paraffin excess and cut into 3-μm-thick sections. As a control, a paraffin block without tissue, which had undergone the same treatment as the tissue containing blocks, was sectioned. Digestion solution was made by adding 100 μl of proteinase K (20 mg/ml; Roche Diagnostics GmbH, Mannheim, Germany) and 10 μl of Tween 20 (Merck BV, Amsterdam, The Netherlands) to 2 ml of TE buffer (1 mmol/L ethylenediaminetetraacetic acid, and 10 mmol/L Tris-HCl buffer, pH 8.0). Approximately 1 to 1.5 cm2 of sectioned tissue (a single section or short ribbons depending on the surface per section) was put in 250 μl of digestion solution and incubated overnight at 45°C. Proteinase K was inactivated by incubation at 100°C for 15 minutes. Samples were centrifuged for 2 minutes at 14,000 rpm. DNA was extracted from the supernatants with QIAamp DNA blood mini kit (Qiagen), according to the manufacturer's instructions (Qiagen protease digestion was not performed), and eluted in 150 μl of buffer AE. TaqMan Assays-on-Demand SNP genotyping products were purchased from Applied Biosystems (Foster City, CA). These assays are predesigned and validated by analyzing DNA samples from 180 individuals of four ethnic origins. The assays are supplied in single tube format and contain two unlabeled primers, a VIC dye-labeled TaqMan MGB probe with the sequence of allele 1 and a FAM dye-labeled TaqMan MGB probe with the sequence of allele 2. SNP amplification assays were used according to the manufacturer's instructions. Twenty-five μl of PCR contained 20 mmol/L Tris-HCl, pH 8.4, 50 mmol/L KCl, 3 mmol/L MgCl2 (prepared from 10× PCR buffer and 50 mmol/L MgCl2 solution delivered with Platinum Taq polymerase), 0.75 U of Platinum Taq polymerase (Invitrogen BV, Breda, The Netherlands), 4% glycerol (molecular biology grade; Calbiochem, VWR International BV, Amsterdam, The Netherlands), 200 μmol/L of each dNTP (Invitrogen BV), 0.5 μl of Rox reference dye (Invitrogen BV), 1.25 μl of predeveloped assay reagent from the Assays-on-Demand SNP genotyping products (Applied Biosystems) containing two primers and two MGB TaqMan probes (5′ VIC for allele 1, 5′ FAM for allele 2, a 3′ black hole quencher), and 11.25 μl of target DNA. Real-time PCR was performed in an ABI Prism 7000 SDS (Applied Biosystems) for 2 minutes at 50°C, 10 minutes at 95°C, followed by 40 cycles of 15 seconds at 95°C and 1 minute at 60°C. From an internet database containing more than 150,000 human TaqMan Assays-on-Demand SNP genotyping products (Applied Biosystems), we selected 17 SNP assays (Table 1). The principle of the assays is explained in Figure 1. An important criterion of selection was that minor (and major) allele frequency of the SNP should be ∼0.5. TaqMan Assays-on-Demand SNP genotyping products (Applied Biosystems) are validated by analyzing DNA samples from 180 individuals of four ethnic origins. Because the Dutch population is mainly of Caucasian origin, we used the Applied Biosystems indicated allele frequencies for Caucasians for the selection of SNP assays. Assuming the genotype frequencies to be in Hardy-Weinberg equilibrium, the chance to have identical outcome of two events (allele 1 versus allele 2) is = p2 + (1 − p)2.21Hardy GH Mendelian proportions in a mixed population.Science. 1908; 28: 49-50Crossref PubMed Scopus (656) Google Scholar,22Weinberg W Über den nachweis der verebung beim menschen.Nat Wüttemberg. 1908; 64: 368-382Google Scholar To minimize this chance, the derivative of this equation equals 0. Thus, 2p − 2 + 2p = 0 and p = 0.5. Another criterion of selection was that all SNPs should be situated on different chromosomes (c.q. autosomes). In addition, the SNPs should not reside within a coding region or the regulatory sequence of a gene. From the 17 SNP assays, the most suitable were selected for a panel of 10 SNP assays that we recommend to be used for the SNP profiling assay (Table 1). Beside the SNP assays, for identity confirmation we included the detection of one sequence specific to the human Y chromosome23Lo YM Tein MS Lau TK Haines CJ Leung TN Poon PM Wainscoat JS Johnson PJ Chang AM Hjelm NM Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.Am J Hum Genet. 1998; 62: 768-775Abstract Full Text Full Text PDF PubMed Scopus (1391) Google Scholar to resolve male/female sample mix-ups.Table 1Assays Selected from Applied Biosystems (ABI)SNPSNP IDPredeveloped assay reagent IDChromosome positionLOH hitsSNP type (gene)Genotype Vic/FamObserved MAFHapMap MAFABI MAF1rs2283839C___2474321_1_22q1221Intron (TPST2)A/C0.48 (n = 122)0.430.52rs1860300C__11445512_1017p13218Intergenic/unknownA/C0.40 (n = 78)Unknown0.53rs2400077C__15792496_105p15.214Intron (CTNND2)A/C0.44 (n = 124)0.450.54rs663528C___1098888_1013q1259Intergenic/unknownG/T0.38 (n = 72)0.460.55rs2239508C___1315434_1_18p1110Intron (RAB31)A/C0.45 (n = 112)0.450.56rs2658509C___1523697_104p15.36Intron (LDB2)A/C0.49 (n = 76)0.420.497rs1610180C___1967983_103p2581Intron (SLC6A11)C/A0.45 (n = 104)Unknown0.58rs1202295C___2511899_106p227Intergenic/unknownA/C0.43 (n = 114)Unknown0.59rs1150964C___3142524_1012p11.22Intergenic/unknownG/T0.44 (n = 90)Unknown0.4910rs2237958C___2574166_1_11p15116Intron (USH1C)A/C0.40 (n = 100)0.450.4911rs2807845C___1235820_101q411FLJ22390/intergenicG/T0.46 (n = 46)0.40.4812rs2305749C__16191595_1019q13.124Intron (HPN)G/T0.27 (n = 30)Unknown0.4913rs1255912C__11462447_1014q235Intron (SYNE2)A/C0.45 (n = 20)0.490.4714rs690054C___1616502_1015q215Intron (WDR72)C/T0.35 (n = 20)0.50.515rs816852C___3240268_1010q2214Intron (KCNMA1)A/G0.40 (n = 20)0.50.516rs12996989C___1174290_102q216Intron (LRP1B)C/G0.40 (n = 20)0.50.517rs656255C___2952210_1012q242Intron (KSR2)A/C0.40 (n = 20)0.50.5Underlined SNP assays are recommended. Other SNP assays are excluded because of LOH (SNP2, SNP4, SNP7, and SNP10), allele frequencies significantly different from 0.5 (SNP4, SNP10, and SNP12), or technical limitations (SNP6 and SNP9). MAF, minor allele frequency. Open table in a new tab Underlined SNP assays are recommended. Other SNP assays are excluded because of LOH (SNP2, SNP4, SNP7, and SNP10), allele frequencies significantly different from 0.5 (SNP4, SNP10, and SNP12), or technical limitations (SNP6 and SNP9). MAF, minor allele frequency. Because blood is an easy source of high-quality DNA, we tested the assays by analyzing four blood samples from four different patients. Figure 2 shows the fluorescent signals of three representative SNP assays; cycle thresholds (Ct values) were ∼23. The presence or absence of alleles 1 and 2 could easily be deduced from the signals (Table 2). All four individuals could easily be distinguished based on their SNP profiles.Table 2SNP Profiles: Presence (+) or Absence (−) of Allele 1 (V) and Allele 2 (F)SNP 1SNP 3SNP 5SNP 8SNP 11SNP 13SNP 14SNP 15SNP 16SNP 17CasePathology numberTissueVFVFVFVFVFVFVFVFVFVFBlood 1−++++−+++++−++++−++−Blood 2−++−−++−++−++−+−+++−Blood 3−++++−+++++−++−+++++Blood 4+−−+−++++−+++−−+−++−11-A-IMammary tissue−++−−+++−++−+−+++−+−1-A-IIMammary tissue−+++++++++−++++−+++−1-BCervical polyp−++−−+++−++−+−+++−+−1-CInfiltrating carcinoma−++−−+++−++−+−+++−+−1-DMammary tissue−+++++++++−++++−+++−1-EMammary tissue−+++++++++−++++−+++−22-Afloater++−++−+−+−++++++++−+2-BMediastinoscopy++−++−+−+−++++++++−+33-ASkin−++++++−+−−+−++−+−++3-BSkin−++++−+++++−++++++++3-CSkin+−++−++−+++++−+−−+++3-DSkin++−++++−+++−−++++++−3-EVocal cord−++++−+++++−++++++++3-FSkin++−++++−+++−−++++++−3-GCurettage+−++−++−+++++−+−−+++44-ASkin+−−+++−++++−+−+−+−++4-BSkin+−−+++−++++−+−+−+−++55-1-1Prostate−++++−++++−+++−++++−5-2-1Prostate+−+++++−++−++−++++−+5-AProstate−++++−++++−+++−++++−15 specimensProstate−++−14 specimensProstate+−++5-1-12Prostate????5-1-13Prostate+−??5-1-16Prostate−+??66-AMammary biopsy+−+−−+++++−+++++++−+6-BMammary tissue+−+−−+++++−+++++++−+6-CMammary tissue+−+−−+++++−+++++++−+?, result not conclusive. Open table in a new tab ?, result not conclusive. To validate the SNP assays on paraffin materials, 35 paraffin-embedded tissues were analyzed in a total of 266 SNP assays. For the 35 tissues, the mean Ct value for fluorescent signals that were considered positive was 27.8 ± 4.2 (mean ± SD). A Ct value of 27.8 is approximately comparable with 104 cells in one PCR. During the processing of paraffin embedding, sectioning, and further analysis by real-time PCR, small traces of foreign DNA may contaminate the tissue under investigation. We therefore included a paraffin block in which no tissue was embedded in all analysis as a negative control. This paraffin block was processed identically to tissue containing blocks. The negative controls generated Ct values of 38.6 FAM and 41.9 (VIC) in 1 of 122 SNP assays. Based on the above findings, we defined the cutoff level for reliable Ct values at 33. Thus, Ct values higher than 33 were rejected, whereas Ct values lower than 33 were accepted. If Ct values exceeded 33, a larger surface of new sections was cut and analyzed. To test statistically whether the observed allele frequencies in the SNP assays differed from the frequencies indicated by Applied Biosystems for the Caucasian population, we used the χ2 test. For each SNP, materials from a minimum of 10 individuals (maximum 62 individuals) were analyzed. With a probability of exceeding the critical value of 0.05, the observed frequencies for SNP4, 10, and 12 differed significantly from the expected frequencies (data not shown). We therefore excluded these SNP assays from the recommended panel of SNP assays (Table 1). LOH may lead to allelic loss and may therefore complicate the analyses of tumor tissues. During the development of the SNP profiling assay, we encountered fluorescent signals indicative of LOH in one lung tumor tissue (case 2, described below). We therefore investigated in silico whether the SNP assays were located in regions implicated in LOH by using the chromosomal region together with LOH as search terms in PubMed (Table 1). 3p25, 11p15, 13q12, and 17p13 yielded between 59 and 218 hits, rendering them less suitable for analysis of tumor tissues. The number of hits for the 10 recommended SNPs varied from 1 to 21. Within the last 3 years, we processed 182,695 specimens. We had 34 potential sample mix-ups in which 111 patient materials were involved. Thus, the potential error percentage was 0.06%. To solve these issues, a total of 29 archived tissue blocks were analyzed. Complete SNP profiles (10 SNPs) were analyzed for 21 tissue-pairs. In eight of those cases, the SNP profiles showed 100% match, and common origin of the tissues was concluded. In the discordant SNP profiles of the other 13 mix-ups, the number of differing SNPs between the two tissues was 3 (n = 3), 4 (n = 1), 5 (n = 3), or ≥6 (n = 6). All issues of possible mix-up were adequately solved by SNP profiling. The elucidation of six representative cases of sample mix-ups is described below. Two mammary needle biopsies were taken from patients 1 and 2, respectively, and processed on the same day. Both tissue blocks were numbered 1-A. Histological analyses revealed that one of them, assigned 1-A-I, showed the presence of an infiltrative ductal carcinoma (Figure 3A), whereas the other, assigned 1-A-II, was benign (Figure 3B). The archive of paraffin-embedded specimens contained a cervical polyp biopsy (1-B) derived from patient 1. Figure 4 and Table 2 show that 1-A-I and 1-B have an identical SNP profile that differed from 1-A-II. Thus 1-A-I was assigned to patient 1 and 1-A-II was assigned to patient 2. Sixteen days after the needle biopsies were taken, patient 1 underwent a mastectomy (1C). A tumor of 28 mm was found and diagnosed as an infiltrative adenocarcinoma (Figure 3C). The SNP profile of this tumor (1C) was identical to the profile of 1-A-I and 1-B of patient 1 (Table 2). One and a half years after the needle biopsies, two other histological needle biopsies were taken from patient 2. Both were diagnosed as benign lesions. The SNP profiles of both tissues were identical to 1-A-II's profile (Table 2, 1-D and 1-E).Figure 4Fluorescent signals (light gray line, VIC; black line, FAM) of three SNP assays performed on DNA isolated from two mammary tissues (1-A-I and 1-A-II) from patients 1 and 2 and a cervical polyp from patient 1 (1-B).View Large Image Figure ViewerDownload Hi-res image Download (PPT) The pathologist noticed a floater (2-A) of lung tumor tissue in a lymph node biopsy obtained by mediastinoscopy (2-B) from patient 3. Microscopically the floater was isolated from the surrounding nodal tissue. The question arose whether the floater and the lymph node were from the same individual. SNP analysis revealed a similar SNP profile of the two tissues (Table 2). Theoretically, the chance to have such a profile is lower than 1 in 30,000 assuming P = 0.5 for the analyzed SNPs: 1/(0.255 × 0.55). In line with this, a keratin PAN immune peroxidase staining of another gland from patient 3 showed the presence of cells resembling the tumor cells in specimen 2-B (data not shown). The VIC signal of SNP14, although clearly present, was lower in the floater compared with the lymph node (Figure 5). SNP14 is located on 15q21, a region for which, to date, no LOH in lung tumor tissue has been reported. Because of a technical failure of the dissection table, four skin biopsies (3-A, 3-B, 3-C, and 3-D) derived from four patients (4, 5, 6, and 7) lost their identification. For three of these patients, archived material was available: a vocal cord of patient 4 (3-E), a skin biopsy of patient 5 (3-F), and curettage of patient 6 (3-G). Table 2 shows that three of the four SNP profiles from the unlabeled skin biopsies matched SNP profiles from the archived tissues. Thus, similar SNP profiles were observed for 3-B and 3-E (patient 4), 3-C and 3-G (patient 6), and 3-D and 3-F (patient 5). The remaining skin biopsy (3-A) was assigned to patient 7. Dutch parents received information that their son had died in a foreign country. A high degree of degradation complicated the identification of the corpse. The parents asked the Jeroen Bosch Hospital to analyze whether a skin biopsy taken postmortem could be their son's. The SNP profile of the postmortem skin biopsy (4-A) was identical to the SNP profile of an archived sample (4-B) of the son. Theoretically, the chance for the observed SNP profile was ∼1 in 130,000. Another laboratory in The Netherlands later analyzed 10 tetranucleotide STR loci and Amelogenin using the AmpFLSTR SGM Plus PCR amplification kit (Applied Biosystems) of muscle and bone tissue of the deceased and mouth epithelial cells of the supposed mother. The DNA profiles very strongly suggested a mother-child relationship between the two individuals involved. Two prostate glands (5-1 from patient 8 and 5-2 from patient 9) were processed sequentially. According to our routine protocol, from each prostate, 17 biopsies were sectioned and labeled. The first sections from both prostates were labeled correctly (5-1-1 and 5-2-1), whereas all of the other sections were assigned to prostate gland 5-1 (two series labeled 5-1-2 to 5-1-17). From patient 8, archived material (5A) was present. An SNP profile was generated from 5-1-1 and 5-2-1 and 5A to determine which SNPs were discriminatory (Table 2). SNP1 and SNP5 (CC and AA for patient 8, AA and AC for patient 9, respectively) were selected to analyze the remaining 32 samples. One section (5-1-12) yielded no results. Because the other section labeled 5-1-12 showed SNP1 and SNP5 alleles of patient 8, this section was assigned to patient 9. Thus, 16 sections could be assigned to patient 8 and 16 sections to patient 9 (Table 2). A mammary biopsy, 6-A, was sent in for analysis and found to be malignant. Mammary tissue was removed by mastectomy and analyzed (6-B and 6-C), but no tumor cells were found. The identical SNP profile of the biopsy and two other tissues (Table 2) rendered the possibility of sample mix-up extremely unlikely (1 in 30,000), which led us to further analyze 6-B and 6-C. Subsequent thorough analysis of the removed mammary tissue revealed a 6-mm medium differentiated malignant tumor in 6-C, thus confirming the exclusion of a sample mix-up. SNP profiling provides a quick, easy, and reliable way to confirm the source of human tissues. The SNP assays to be used to generate an SNP profile were carefully selected to meet certain criteria. We chose a symmetrical distribution of allele frequency (SNPs with minor, and major, allele frequency of ∼0.5) to maximize the chance that individuals can be distinguished on their SNP profile while analyzing a limited number of SNPs. To minimize the chance of linkage, the 10 SNPs were chosen on 10 different chromosomes. If an SNP consists of two variants (ie, A and C) an individual has three possibilities (AA, AC, and CC). Thus, for 10 SNPs, 310 (59,049) different profiles exist. Assuming the genotype frequencies to be in Hardy-Weinberg equilibrium, when 10 independent SNPs with P = 0.5 are analyzed, the chance for two randomly selected individuals to have the same genotype for one SNP is 0.252 + 0.52 + 0.252 = 0.375. For 10 SNPs, this chance is 0.37510 = 1 in 18,000. If the minor allele frequency is 0.4, this chance is 0.3856510 = 1 in 14,000, with minor allele frequency of 0.2 this chance is 1 in 900. Thus, the resolution of the test is acceptable in the range of 0.4 < P < 0.5 but diminishes with more asymmetrical allele frequencies. Three SNP assays (SNP4, SNP10, and SNP12) with observed allele frequencies that differed significantly (χ2 test; P value of 0.05) from 0.5 were excluded from the recommended SNP panel. For the Hardy-Weinberg equilibrium, the following assumptions are made: 1) individuals from the population are diploid and reproduce sexually; 2) the population size is infinite; 3) there is no movement from one population to the other; 4) there is no mutation (no biochemical changes in DNA that produce new alleles); 5) mating is random (this means that individuals do not select mates based on the genotype of the SNPs); and 6) the different genotypes of the SNPs have equal fitness. The 10 selected SNPs were located on 10 autosomes, ensuring that two copies of each selected locus are present (diploid) in each individual. Because most people in The Netherlands are of Caucasian origin, a population that is reasonably assumed to be infinite, we selected SNPs with P values of ∼0.5 within the Caucasian population. Because allele frequencies differ from one population to the other, the resolution of the test within a non-Caucasian population is lower because of more asymmetrical distribution of alleles. Assuming allele frequencies indicated by Applied Biosystems, for African Americans the discriminatory power of the test using the 10 recommended SNP assays is in the order of 4 × 103, for Chinese and Japanese even lower, 103. Thus for an SNP profiling test, it is important to select SNPs on the basis of allele frequencies within the population studied. With a limited number of people from other populations present in a Caucasian population, however, the test as presented here will maintain its resolution. Mutation rate in mammalian germ cells is low, estimated to be in the order of 1 × 105 per locus per gene-ration.24Russell LB Russell WL Frequency and nature of specific-locus mutations induced in female mice by radiations and chemicals: a review.Mutat Res. 1992; 296: 107-127Crossref PubMed Scopus (93) Google Scholar,25Kuick RD Neel JV Strahler JR Chu EH Bargal R Fox DA Hanash SM Similarity of spontaneous germinal and in vitro somatic cell mutation rates in humans: implications for carcinogenesis and for the role of exogenous factors in "spontaneous" germinal mutagenesis.Proc Natl Acad Sci USA. 1992; 89: 7036-7040Crossref PubMed Scopus
Referência(s)